KALA BIO INCORPORATED (KALA)

KLA (KLAC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Investing.com -- KLA Corporation’s fiscal Q4 FY2026 earnings delivered a clean beat — $3.66B in revenue (+15% YoY) and $1.05 adjusted EPS vs. $1.00 consensus — yet the stock is down ~10% today to $179, a "sell the news" reaction driven by a guidance range that left bulls wanting more.

Moby summary of KLA Corporation's Q4 2026 earnings call

KLA Corporation (NASDAQ:KLAC) reported stronger-than-expected fiscal fourth-quarter results, but its shares fell more than 10% in pre-market trading on Wednesday after investors focused on a cautious near-term outlook and guidance that offered only limited upside.

KLA Corp (KLAC) achieves record revenue of $3.66 billion, driven by AI infrastructure demand, while navigating supply chain and pricing pressures.